A Novel Wound Retractor Combining Continuous Irrigation and Barrier Protection Reduces Incisional Contamination and Surgical Site Infection in Colorectal Surgery

Sponsor
The Cleveland Clinic (Other)
Overall Status
Recruiting
CT.gov ID
NCT03816995
Collaborator
(none)
702
1
2
51.6
13.6

Study Details

Study Description

Brief Summary

Surgical site infection (SSI) remains a problem in colorectal surgery. Strategies to reduce the incidence of SSI following colorectal surgery are important to improve overall patient outcomes, reduce healthcare-associated costs and provide value-based healthcare to surgical patients.

Preventing contamination of the wound through the use of barrier wound protectors or intraoperative wound irrigation has shown significant promise individually and is an ongoing focus to reduce wound infections SSI.

Condition or Disease Intervention/Treatment Phase
  • Device: CleanCision Wound Retraction and Protection System
  • Device: Alexis O Wound Protector
N/A

Detailed Description

Surgical site infection (SSI) remains a persistent and morbid problem in colorectal surgery with published rates ranging from 7 to 25%. The negative outcomes of SSI are well reported and include a significant increase in morbidity, length of hospital stay, readmissions and healthcare-associated cost. Therefore, strategies to reduce the incidence of SSI following colorectal surgery are important to improve overall patient outcomes, reduce healthcare-associated costs and provide value-based healthcare to surgical patients.

Key to the pathogenesis of SSI is the degree of bacterial contamination of the surgical wound. Preventing contamination of the wound or reducing the bacterial load through the use of barrier wound protectors or intraoperative wound irrigation has shown significant promise individually and is an ongoing strategic focus to reduce wound infections after surgery.

The usage of intraoperative wound irrigation has been shown to significantly reduce the risk of SSI via multiple RTC. A surgical device that combines continuous wound irrigation and barrier protection will have an important SSI prevention advantage.

CleanCision is a recently developed apparatus that serves this purpose and was found to reduce bacterial wound contamination in preclinical and clinical trials.

This study aims to investigate the effect of using CleanCision wound protector on the rates of postoperative Surgical Site Infections in comparison to the current wound protector (Alexis O) being used at our institute.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
702 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
A Novel Wound Retractor Combining Continuous Irrigation and Barrier Protection Reduces Incisional Contamination and Surgical Site Infection in Colorectal Surgery
Actual Study Start Date :
Feb 12, 2019
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Jun 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Alexis O Wound Protector

Participants will undergo standard surgical procedure using the Alexis O wound protector.

Device: Alexis O Wound Protector
wound retraction

Experimental: CleanCision Wound Protector

Participants will undergo standard surgical procedure using the CleanCision Wound Retraction and Protection System

Device: CleanCision Wound Retraction and Protection System
wound retraction and irrigation

Outcome Measures

Primary Outcome Measures

  1. Surgical Site Infection rate [30 days]

    To evaluate the 30 day post-operative SSI rate in patients undergoing elective colorectal surgical procedures after intraoperative usage of Alexis O wound protector vs. CleanCision continuous irrigation wound protector.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Patients 18 years old and above.

  2. Elective colorectal surgery with a planned resection including open or laparoscopic surgeries.

  3. Clean -contaminated, contaminated and dirty wounds per the definition above.

  4. Patients undergoing Standard of care SSI reduction bundle including Prophylactic AB and mechanical bowel preparation.

  5. Anticipated incision length of 3-17 cm

Exclusion Criteria:
  1. Patients younger than 18 years old.

  2. Patients with a preexisting stoma.

  3. Patiens with prior laparotomy within 15 days.

  4. Patients with an active infection or systemic antibiotic therapy within 1 week prior to surgery with the exception of preoperative antimicrobial prophylaxis.

  5. Emergent/ urgent surgery.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cleveland Clinic Foundation Cleveland Ohio United States 44195

Sponsors and Collaborators

  • The Cleveland Clinic

Investigators

  • Principal Investigator: Scott Steele, MD, The Cleveland Clinic

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Scott Steele, Department Chair, The Cleveland Clinic
ClinicalTrials.gov Identifier:
NCT03816995
Other Study ID Numbers:
  • 18-1346
First Posted:
Jan 25, 2019
Last Update Posted:
Feb 21, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Scott Steele, Department Chair, The Cleveland Clinic
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 21, 2022